Scholarlink

Purpose <p>We examined the impact of cancer-related cognitive impairment (CRCI) after systemic or radiation therapy for breast or gynaecologic cancer on return to work (RTW) and quality of working life (QWL).</p> Methods <p>The analyses included 147 women diagnosed with breast or gynecologic cancer from the CogniFiT study who were 18–65&#xa0;years old and employed at diagnosis. We assessed objective cognitive function (visual search, executive function, and verbal memory), subjective cognitive function (FACT-Cog), and other patient-reported outcomes before primary systemic or radiation therapy (T0), at the end of it (T1), and 1&#xa0;year later (T2). Patients reported on RTW until T2 and, if applicable, QWL (QWLQ-CS). Logistic regressions on RTW and multiple regressions on QWL were calculated separately for each cognitive variable and patient-reported outcome and were adjusted for education, age, marital status, and chemotherapy.</p> Results <p>At T2, 77.6% of patients had returned to work. Higher impairments in executive function, i.e., working memory (OR = 0.45, 95% CI [0.23–0.80]) and task-switching ability (OR = 0.48, 95% CI [0.25–0.82]) at T1, were associated with a lower likelihood for RTW at T2. Subjective cognitive impairments were not associated with RTW, but with lower QWL (<i>β</i> = − 0.35, 95% CI [− 0.53 to − 0.16]). Other patient-reported outcomes also showed no associations with RTW but were associated with QWL.</p> Conclusions <p>Deficits in executive function, but not other domains, may hinder return to work. Subjective and objective measures of cognition relate to work outcomes differently.</p> Implications for Cancer Survivors <p>Clinicians should openly address cognitive impairments as affected survivors may need additional support and workplace adaptations when returning to work.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The role of cognitive impairments in patients’ return to work and quality of working life after treatment of breast or gynecologic cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月20日

查看全文
  • Alina Kias,
  • Martina E. Schmidt,
  • Karen Steindorf

摘要

Purpose

We examined the impact of cancer-related cognitive impairment (CRCI) after systemic or radiation therapy for breast or gynaecologic cancer on return to work (RTW) and quality of working life (QWL).

Methods

The analyses included 147 women diagnosed with breast or gynecologic cancer from the CogniFiT study who were 18–65 years old and employed at diagnosis. We assessed objective cognitive function (visual search, executive function, and verbal memory), subjective cognitive function (FACT-Cog), and other patient-reported outcomes before primary systemic or radiation therapy (T0), at the end of it (T1), and 1 year later (T2). Patients reported on RTW until T2 and, if applicable, QWL (QWLQ-CS). Logistic regressions on RTW and multiple regressions on QWL were calculated separately for each cognitive variable and patient-reported outcome and were adjusted for education, age, marital status, and chemotherapy.

Results

At T2, 77.6% of patients had returned to work. Higher impairments in executive function, i.e., working memory (OR = 0.45, 95% CI [0.23–0.80]) and task-switching ability (OR = 0.48, 95% CI [0.25–0.82]) at T1, were associated with a lower likelihood for RTW at T2. Subjective cognitive impairments were not associated with RTW, but with lower QWL (β = − 0.35, 95% CI [− 0.53 to − 0.16]). Other patient-reported outcomes also showed no associations with RTW but were associated with QWL.

Conclusions

Deficits in executive function, but not other domains, may hinder return to work. Subjective and objective measures of cognition relate to work outcomes differently.

Implications for Cancer Survivors

Clinicians should openly address cognitive impairments as affected survivors may need additional support and workplace adaptations when returning to work.